No Data
9 consecutive limits up. Meibang Co., Ltd. (605033.SH): has reached two serious abnormal situations. The passing the buck is very obvious, and it may rapidly decline at any time.
Meibang Co., Ltd. (605033.SH) announced that the company's stock price has significantly deviated from market and Industry trends: since 20...
MEIBANG Holdings (605033.SH): The 'musical chairs' effect of the company's Stocks is very obvious.
Gelonghui, January 14th丨Meibang Co., Ltd. (605033.SH) announced a stock trading risk reminder. The company's main business includes the research, production, sales of pesticide products, as well as agricultural technology promotion and services. Currently, production and operation are normal, and there have been no significant changes in the main business compared to the external environment. The "one certificate, one product" policy has a minor impact on the company. In the first three quarters of 2024, the net income attributable to shareholders of the listed company was 43,276,200.59 yuan, a decrease of 38.34% compared to the same period last year. It is expected that the net income attributable to shareholders of the listed company will continue to decline compared to the same period last year.
Meibang Shares (605033.SH) with 8 consecutive trading limits: The "one certificate, one product" policy has little impact on the company.
Meibang Co., Ltd. (605033.SH) announced a severe abnormal fluctuation in Trade, and the company's Stocks will be suspended from trading from January 2025...
The 5 consecutive limit-up days for Mebon Co., Ltd. (605033.SH): The "one certificate, one product" policy has little impact on the company.
On January 8, Gelonghui reported that Meibang Co., Ltd. (605033.SH) announced that the "one certificate, one product" policy has a minor impact on the company. The company has been complying with national policies for registration, and its production and operation are currently normal. There have been no significant changes in the main Business, and the external environment has not changed significantly. Given the recent volatility in the company's Stocks trading prices, which have closed at the limit-up price for five consecutive trading days, there is a high risk of speculation. The company's main Business focuses on the research, production, and sales of pesticide products, as well as the promotion and service of Agriculture technology, and currently, its production and operation are normal with no significant changes in the main Business, and the external environment has not undergone significant changes.
What Shaanxi Meibang Pharmaceutical Group Co., Ltd.'s (SHSE:605033) 28% Share Price Gain Is Not Telling You
Three consecutive boards & "Heaven and Earth" giant shock. Meibang Co., Ltd. (605033.SH): Trade volume has increased significantly, Operation is normal and there are no major changes in the main business.
Meibang Co., Ltd. (605033.SH) announced that the company's Stocks will be continuously suspended on January 2 and January 3, 2025...